Sarepta Therapeutics (SRPT) FCF Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 10,029.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 723.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,409.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,066.00 |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 3,519.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,519.00 |
| Dec 31, 2025 | 8,813.00 |
| Sep 30, 2025 | 2,583.00 |
| Jun 30, 2025 | 7,350.00 |
| Mar 31, 2025 | 1,469.00 |
| Dec 31, 2024 | 3,636.00 |
| Sep 30, 2024 | 4,741.00 |
| Jun 30, 2024 | 7,719.00 |
| Mar 31, 2024 | 7,076.00 |
| Dec 31, 2023 | 88,721.00 |
| Sep 30, 2023 | 112,781.00 |
| Jun 30, 2023 | -14,263.00 |
| Mar 31, 2023 | -476,402.00 |
| Dec 31, 2022 | 12,153.00 |
| Sep 30, 2022 | 4,238.00 |
| Jun 30, 2022 | 6,514.00 |
| Mar 31, 2022 | -29,825.00 |
| Dec 31, 2021 | 14,079.00 |
| Sep 30, 2021 | 9,946.00 |
| Jun 30, 2021 | 9,019.00 |
| Mar 31, 2021 | -6,311.00 |
| Dec 31, 2020 | -84,208.00 |
| Sep 30, 2020 | -104,366.00 |
| Jun 30, 2020 | -23,583.00 |
| Mar 31, 2020 | 505,923.00 |
| Dec 31, 2017 | 10.58 Mn |
| Sep 30, 2017 | 438,461.00 |
| Jun 30, 2017 | 145,278.00 |
| Mar 31, 2017 | 17,021.00 |